Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison
Joy Feld, Vinod Chandran, Nigil Haroon, et al.
Nature Reviews Rheumatology (2018) Vol. 14, Iss. 6, pp. 363-371
Closed Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
Atul Deodhar, Lianne S. Gensler, Joachim Sieper, et al.
Arthritis & Rheumatology (2018) Vol. 71, Iss. 2, pp. 258-270
Open Access | Times Cited: 284
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
Xenofon Baraliakos, Laure Gossec, Effie Pournara, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 5, pp. 582-590
Open Access | Times Cited: 143
Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data
Imke Redeker, Johanna Callhoff, Falk Hoffmann, et al.
Lara D. Veeken (2019) Vol. 58, Iss. 9, pp. 1634-1638
Closed Access | Times Cited: 132
Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
Joy Feld, Justine Yang Ye, Vinod Chandran, et al.
Lara D. Veeken (2019) Vol. 59, Iss. 6, pp. 1340-1346
Open Access | Times Cited: 119
Axial involvement in psoriatic arthritis: An update for rheumatologists
Denis Poddubnyy, Deepak R. Jadon, Filip Van den Bosch, et al.
Seminars in Arthritis and Rheumatism (2021) Vol. 51, Iss. 4, pp. 880-887
Open Access | Times Cited: 76
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
Philip J. Mease, Philip Helliwell, Dafna D. Gladman, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 10, pp. e715-e723
Open Access | Times Cited: 74
Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities
Alan Menter, Gerald G. Krueger, So Yeon Paek, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 2, pp. 385-400
Open Access | Times Cited: 61
Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis
Fataneh Tavasolian, Starlee Lively, Chiara Pastrello, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 11, pp. 1429-1443
Closed Access | Times Cited: 28
Axial psoriatic arthritis: An update for dermatologists
Alice B. Gottlieb, Joseph F. Merola
Journal of the American Academy of Dermatology (2020) Vol. 84, Iss. 1, pp. 92-101
Open Access | Times Cited: 65
The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA–B27 Status?
Laura C. Coates, Xenofon Baraliakos, Francisco J. Blanco, et al.
Arthritis Care & Research (2020) Vol. 73, Iss. 6, pp. 856-860
Open Access | Times Cited: 58
The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
Matteo Vecellio, Vivien Xanath Hake, Connor Davidson, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 54
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch, et al.
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13
Open Access | Times Cited: 54
From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention
Alen Zabotti, Ilaria Tinazzi, Sibel Zehra Aydın, et al.
Current Rheumatology Reports (2020) Vol. 22, Iss. 6
Open Access | Times Cited: 52
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study
Maria Sole Chimenti, Giulia Lavinia Fonti, Paola Conigliaro, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 7, pp. 813-821
Open Access | Times Cited: 52
Clinical features of psoriatic arthritis
Mitsumasa Kishimoto, Gautam A. Deshpande, Kazuhito Fukuoka, et al.
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 2, pp. 101670-101670
Closed Access | Times Cited: 46
A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
Iain B. McInnes, Zoltán Szekanecz, Dennis McGonagle, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 5, pp. 1783-1794
Open Access | Times Cited: 41
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials
Philip Helliwell, Dafna D. Gladman, Soumya D. Chakravarty, et al.
RMD Open (2020) Vol. 6, Iss. 1, pp. e001149-e001149
Open Access | Times Cited: 48
Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin‐17 Inhibitors: A Nationwide Population‐Based Study Using the French National Health Data System
Laëtitia Penso, Christina Bergqvist, Antoine Meyer, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 2, pp. 244-252
Closed Access | Times Cited: 37
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023
Kevin Winthrop, Philip J. Mease, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 4, pp. 409-416
Open Access | Times Cited: 15
Psoriasis and Psoriatic Arthritis—Associated Genes, Cytokines, and Human Leukocyte Antigens
Marek Zalesak, Ľuboš Danišovič, Stefan Harsanyi
Medicina (2024) Vol. 60, Iss. 5, pp. 815-815
Open Access | Times Cited: 5
Axial Psoriatic Arthritis
Dafna D. Gladman
Current Rheumatology Reports (2021) Vol. 23, Iss. 6
Closed Access | Times Cited: 28
Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs
Monica Schwartzman, Joerg Ermann, Kristine A. Kuhn, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e001777-e001777
Open Access | Times Cited: 21
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
Arthur Kavanaugh, Xenofon Baraliakos, Sheng Gao, et al.
Advances in Therapy (2023) Vol. 40, Iss. 5, pp. 2439-2456
Open Access | Times Cited: 12
Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocol
Sam G. Edalat, Reto Gerber, Miranda Houtman, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109707-109707
Open Access | Times Cited: 4
Axial involvement in a cohort of patients with psoriatic arthritis
Nermeen Samy, Abdul‐Rauf Sayed, Sherin H. Hamza, et al.
The Egyptian Rheumatologist (2025) Vol. 47, Iss. 2, pp. 74-79
Closed Access
Page 1 - Next Page

Scroll to top